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Abstract
OBJECTIVE—To determine the association (1) between shorter operative duration and surgical 
site infection (SSI) and (2) between surgeon median operative duration and SSI risk among first-
time hip and knee arthroplasties.
DESIGN—Retrospective cohort study
SETTING—A total of 43 community hospitals located in the southeastern United States.
PATIENTS—Adults who developed SSIs according to National Healthcare Safety Network 
criteria within 365 days of first-time knee or hip arthroplasties performed between January 1, 2008 
and December 31, 2012.
METHODS—Log-binomial regression models estimated the association (1) between operative 
duration and SSI outcome and (2) between surgeon median operative duration and SSI outcome. 
Hip and knee arthroplasties were evaluated in separate models. Each model was adjusted for 
American Society of Anesthesiology score and patient age.
RESULTS—A total of 25,531 hip arthroplasties and 42,187 knee arthroplasties were included in 
the study. The risk of SSI in knee arthroplasties with an operative duration shorter than the 25th 
percentile was 0.40 times the risk of SSI in knee arthroplasties with an operative duration between 
the 25th and 75th percentile (risk ratio [RR], 0.40; 95% confidence interval [CI], 0.38–0.56; P <.
01). Short operative duration did not demonstrate significant association with SSI for hip 
arthroplasties (RR, 1.04; 95% CI, 0.79–1.37; P =.36). Knee arthroplasty surgeons with shorter 
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median operative durations had a lower risk of SSI than surgeons with typical median operative 
durations (RR, 0.52; 95% CI, 0.43–0.64; P <.01).
CONCLUSIONS—Short operative durations were not associated with a higher SSI risk for knee 
or hip arthroplasty procedures in our analysis.
Surgical site infections (SSIs) are the most common hospital-acquired infection1 and can 
result in substantial patient morbidity. Understanding and mitigating patient-specific and 
surgery-specific SSI risk factors can help prevent SSI.2
Prolonged operative duration is a known risk factor for SSI in hip and knee 
arthroplasties,3–11 but the association between short operative durations and SSI outcomes 
has not been extensively studied. While performing outbreak investigations in our 
community hospital network, we observed an increased SSI rate after knee arthroplasty 
procedures performed by one orthopedic surgeon with very short operative durations 
compared with his peers. Based on this observation, we sought to systematically evaluate the 
association between short operative duration and risk of SSI; our a priori hypothesis was 
that short operative durations would be associated with increased SSI rates due to poor 
surgical technique or more frequent breaches in infection control practices. To test this 
hypothesis, we analyzed surveillance data from community hospitals to determine the 
association between shorter operative durations and SSI outcomes in hip and knee 
arthroplasties. We also examined the association between surgeon median operative 
durations and SSI outcomes to determine whether the risk of SSI changed with a surgeon’s 
typical operating speed.
METHODS
We performed a retrospective cohort analysis of prospectively collected SSI surveillance 
data on hip and knee arthroplasties from hospitals participating in the Duke Infection 
Control Outreach Network (DICON). DICON is a network of more than 40 community 
hospitals in 5 states throughout the southeastern United States that has been described 
previously.12 Trained infection preventionists at each hospital collect surveillance data using 
a standardized database employing National Healthcare Safety Network (NHSN) 
definitions. DICON liaison infection preventionists validate a subset of surveillance data 
each month.
Adults (age ≥18 years) who developed SSIs by NHSN criteria13 following first-time, clean 
knee or hip arthroplasties performed between January 1, 2008, and December 31, 2012, 
were included in the analysis (N = 67,718). During the study period, postoperative 
surveillance for a deep incisional SSI or organ-space SSI continued for 1 year. Postoperative 
surveillance for a superficial incisional SSI continued for 30 days. A total of 43 hospitals 
had complete exposure and outcome data and contributed to the study.
Separate log-binomial regression models were created to estimate the association (1) 
between operative duration (independent variable) and SSI outcome (dependent variable) 
and (2) between surgeon median operative duration (independent variable) and SSI outcome 
(dependent variable) in hip and knee arthroplasties. Operative duration is defined as the time 
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between skin incision and skin closure; it was modeled in three categories based on the 
variable’s overall distribution: (1) operative durations shorter than the 25th percentile, (2) 
operative durations between and including the 25th and 75th percentile, and (3) operative 
durations longer than the 75th percentile. This distribution was selected for 2 reasons 
following exploratory analyses. First, operative duration was best represented as a 
categorical variable and the selected cutoff points corresponded with the overall trend of SSI 
risk across operative duration. Second, the National Nosocomial Infections Surveillance risk 
index uses the 75th percentile as a cutoff point to designate procedures with longer duration 
as having higher risk for SSI.4 Surgeon median operative duration was modeled similarly to 
operative duration: (1) surgeon median operative durations shorter than the 25th percentile, 
(2) surgeon median operative durations between and including the 25th and 75th percentile, 
and (3) surgeon median operative durations longer than the 75th percentile. Hip 
arthroplasties and knee arthroplasties were evaluated in separate models for 4 models. 
American Society of Anesthesiology (ASA) score and patient age were considered potential 
confounders of the relationship between operative duration and SSI and between surgeon 
median operative duration and SSI. Patient age was modeled as a continuous variable. ASA 
score was modeled as a binary variable (1–2 vs 3–5).4 Bivariate analyses were performed to 
examine relationships between potential confounders, operative duration, surgeon median 
operative duration, and SSI risk. Backward selection was performed for final model 
selection. Confounders that changed the exposure β coeffficient more than 10% were 
retained in the final model.
We then performed multiple sensitivity analyses to evaluate the association between short 
operative duration and risk of SSI while using different definitions for short operative 
duration and inclusion/exclusion criteria. First, we altered the categories for operative 
duration so that short operative times were lower than the 20th percentile. Second, we altered 
the categories for operative duration so that short operative times were lower than the 10th 
percentile. Third, we looked at operative duration as a continuous variable. Fourth, we 
excluded outlier operative duration observations and looked at operative duration as a 
categorical variable as initially described. Other than the alteration noted for each sensitivity 
analysis, model development was performed using the methods described above for each 
model.
Statistical analyses were performed using SAS software, version 9.3 (SAS Institute, Cary, 
North Carolina). This study was approved by the Duke University and the University of 
North Carolina at Chapel Hill Institute Review Boards.
RESULTS
Knee Arthroplasty Results
A total of 42,187 knee arthroplasties performed by 314 surgeons (Table 1) were included in 
the study. The overall SSI rate during the study period was 1.03 SSIs per 100 procedures. 
The median operative duration for knee arthroplasties was 83 minutes (interquartile range 
[IQR], 64–106 minutes). The median age of patients undergoing knee arthroplasty was 67 
years (IQR, 59–74).
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Operative duration and SSI risk in knee arthroplasties—The unadjusted risk of SSI 
in knee arthroplasties with an operative duration shorter than the 25th percentile was 0.40 
times the risk of SSI in knee arthroplasties with an operative duration between the 25th and 
75th percentile (RR, 0.40; 95% confidence interval [CI], 0.28–0.56; P ≤.01). The unadjusted 
risk of SSI in knee arthroplasties with an operative duration longer than the 75th percentile 
was 1.26 times the risk of SSI in knee arthroplasties with an operative duration between the 
25th and 75th percentile (RR, 1.26; 95% CI, 1.18–1.34; P ≤ .01). Patients with shorter 
operative durations were older and did not differ in terms of their ASA scores (Table 1). 
Patients who developed SSIs after knee arthroplasty were younger, had higher ASA scores, 
and had longer operative durations (Table 2). However, none of these potential confounders 
changed the association between operative duration and SSI outcome in knee arthroplasties.
Surgeon median operative duration and SSI risk in knee arthroplasties—The 
unadjusted risk of SSI in knee arthroplasties performed by a surgeon whose median 
operative duration was shorter than the 25th percentile was 0.52 times the risk of SSI in knee 
arthroplasties performed by a surgeon whose median operative duration was between the 
25th and 75th percentile (RR, 0.52; 95% CI, 0.43–0.64; P ≤ .01). The unadjusted risk of SSI 
in knee arthroplasties performed by a surgeon whose median operative duration was longer 
than the 75th percentile was not significantly different than the risk of SSI in knee 
arthroplasties performed by a surgeon whose median operative duration was between the 
25th and 75th percentile (RR, 0.93; 95% CI, 0.68–1.29; P =.68). Surgeons who had a shorter 
median operative time compared to their peers operated on patients with higher ASA scores 
(Table 1). Patients who developed SSI after knee arthroplasty were younger, had higher 
ASA scores, and had their arthroplasty performed by a surgeon who had a typical median 
operative duration (Table 2). However, none of these potential confounders changed the 
association between surgeon median operative duration and SSI outcome in knee 
arthroplasties.
Hip Arthroplasty Results
A total of 25,531 hip arthroplasties performed by 446 surgeons (Table 3) were included in 
the study. The overall SSI rate during the study period was 1.33 SSIs per 100 procedures. 
The median operative duration for hip arthroplasties was 80 minutes (IQR 61–105 minutes). 
The median age of patients undergoing hip arthroplasty was 69 years (IQR, 59–79).
Operative duration and SSI risk in hip arthroplasties—The unadjusted risk of SSI 
in hip arthroplasties with an operative duration shorter than the 25th percentile was not 
significantly different than the risk of SSI in hip arthroplasties with an operative duration 
between the 25th and 75th percentile (RR, 1.05; 95% CI, 0.80–1.38; P =.70). The unadjusted 
risk of SSI in hip arthroplasties with an operative duration longer than the 75th percentile 
was 1.11 times the risk of SSI in hip arthroplasties with an operative duration between the 
25th and 75th percentile (RR, 1.11; 95% CI, 1.03–1.21; P = .01). Patients with shorter 
operative durations tended to be older and to have higher ASA scores (Table 3). Patients 
who developed SSIs after hip arthroplasty had higher ASA scores and longer operative 
durations (Table 4). In the multivariate analysis, patient age confounded the relationship 
between operative duration and SSI risk for hip arthroplasties. After adjusting for patient 
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age, short operative duration was not associated with SSI outcome for hip arthroplasties 
(RR, 1.04; 95% CI, 0.79–1.37; P =.77), whereas long operative duration was associated with 
increased risk of SSI (RR, 1.12; 95% CI, 1.03–1.21; P = .01).
Surgeon median operative duration and SSI risk in hip arthroplasties—The 
unadjusted risk of SSI in hip arthroplasties performed by a surgeon whose median operative 
duration was shorter than the 25th percentile was not significantly different than the risk of 
SSI in knee arthroplasties performed by a surgeon whose median operative duration was 
between the 25th and 75th percentile (RR, 1.11; 95% CI, 0.88–1.41; P = .37). The unadjusted 
risk of SSI in knee arthroplasties performed by a surgeon whose median operative duration 
was longer than the 75th percentile was not significantly different than the risk of SSI in 
knee arthroplasties performed by a surgeon whose median operative duration was between 
the 25th and 75th percentile (RR, 1.10; 95% CI, 0.81–1.50; P = 0.55). Surgeons performing 
hip arthroplasties who had a shorter median operative time compared to their peers tended to 
operate on younger patients and patients with higher ASA scores (Table 3). Patients who 
developed SSI after hip arthroplasty had higher ASA scores (Table 4). None of these 
potential confounders significantly changed the association between surgeon median 
operative duration and SSI outcome in hip arthroplasties.
Sensitivity Analyses
We performed multiple sensitivity analyses using different definitions of short operative 
duration. None of the results provided above were meaningfully altered during any of our 
sensitivity analyses (data not shown).
DISCUSSION
Our a priori hypothesis was incorrect: short operative duration was not associated with a 
higher SSI risk after hip and knee arthroplasties in this cohort of nearly 70,000 patients who 
underwent first-time, clean hip and knee arthroplasties. In fact, we found that short operative 
duration was protective against SSI after knee arthroplasties: patients whose knee 
arthroplasties were performed in <1 hour had just over half the SSI risk of patients whose 
knee arthroplasties were completed within 64–106 minutes. Interestingly, there was no 
association between short operative duration and SSI outcome for hip arthroplasties. 
Conversely, patients undergoing a knee or hip arthroplasty procedures that had an operative 
duration >75th percentile had a higher risk of SSI, which is consistent with prior 
research.3–11 To our knowledge, no other study has investigated the relationship between 
short operative duration and SSI risk in hip and knee arthroplasties.
Our study was developed after we observed that one surgeon involved in an SSI outbreak 
after knee arthroplasties had shorter median operative times than his peers in our network of 
community hospitals. We explored the association between surgeon median operative 
duration and SSI outcomes in an attempt to examine operative duration as a surgeon-specific 
factor rather than as a singular procedure-specific factor. Surgeons performing knee 
arthroplasties who had a median operative duration <79 minutes had a significant protective 
association with SSI outcome compared to surgeons who took longer to perform knee 
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arthroplasties, but this same relationship was not observed for surgeons performing hip 
arthroplasties.
This retrospective analysis has limitations. First, our results were derived from surveillance 
data in community hospitals and may not be generalizable to other practice settings. 
However, we believe our cohort of hospitals to be representative of a typical hospital in the 
United States. Second, we were unable to adjust for some potential confounders such as 
body mass index, specific patient comorbidities, and differences in operating room practices 
among hospitals because these data are not currently included in our surveillance database. 
Third, the surveillance data in the surgical database do not distinguish between initial and 
revision surgeries; thus, we included only the first hip arthroplasty and the first knee 
arthroplasty per patient in the database. However, the large number of arthroplasties in this 
study likely buffers against influential selection bias.
Finally, surgeon experience is a known risk factor for SSI14–17 and may have a direct impact 
on operative duration. We considered using volume of surgeries as a marker of surgeon 
experience. However, surgeons in our community hospitals may also operate in hospitals 
that do not participate in our network; thus, the volume of surgeries performed in our 
network may not reflect an individual’s total surgical volume. Furthermore, we are unable to 
obtain information on other important components of surgeon experience including age and/ 
or years from training. Interestingly, surgeons with higher median operative durations than 
their peers performed fewer total procedures than surgeons with short or typical median 
operative times. It is possible that surgeons with less experience tend to perform longer 
surgeries, thereby increasing their SSI risk.
In conclusion, short operative durations were not associated with a higher SSI risk for knee 
or hip arthroplasty procedures in our analysis. In contrast, our findings provide further 
support to the theory that SSI risk increases with the length of time that the surgical wound 
is open.
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TABLE 2
Distribution of Operative Duration, Surgeon Median Operative Time, and American Society of 
Anesthesiology Score with Surgical Site Infection Outcome in Knee Arthroplasties
Variable Total (N =42,187), No. (%) SSI, No. (rate per 100 procedures) Risk Ratio (95% CI)a
Age (median, IQR) 67 (59–74) 63 (56–71) …
ASA score
 1–2 19,276 (46) 177 (0.92) Reference
 3–5 22,911 (54) 256 (1.12) 1.22 (1.01–1.47)
Operative durationb
 <25% 10,200 (24) 38 (0.37) 0.40 (0.28–0.56)
 25%–75% 21,653 (51) 203 (0.94) Reference
 >75% 10,334 (25) 192 (1.86) 1.98 (1.63–2.41)
Surgeon’s median operative durationc
 <25% 20,022 (47) 140 (0.70) 0.52 (0.43–0.64)
 25%–75% 18,720 (44) 250 (1.34) Reference
 >75% 3,445 (8) 43 (1.25) 0.93 (0.68–1.29)
NOTE. SSI, surgical site infection; IQR, interquartile range; ASA, American Society of Anesthesiology.
a
Unadjusted risk ratio with 95% confidence intervals.
b
Knee arthroplasty operative duration: <25% =<64 min; 25%–75% =64–106 min; >75% =>106 min.
c
Surgeon’s median operative duration: <25% =<79 min; 25%–75% =79–120 min; >75% = >120 min.
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TABLE 4
Distribution of Operative Duration, Surgeon Median Operative Time, and American Society of 
Anesthesiology Score with Surgical Site Infection Outcome in Hip Arthroplasties
Variable Total (N =25,531), No. (%) SSI, No. (Rate per 100 Procedures) Risk Ratio (95% CI)a
Age (median, IQR) 69 (59–79) 69 (60–80) …
ASA score
 1–2 10,905 (43) 98 (0.90) Reference
 3–5 14,626 (57) 242 (1.65) 1.84 (1.46–2.33)
Operative durationb
 <25% 6,064 (24) 77 (1.27) 1.05 (0.80–1.38)
 25%–75% 13,207 (52) 159 (1.20) Reference
 >75% 6,260 (24) 104 (1.66) 1.38 (1.08–1.76)
Surgeon’s median operative durationc
 <25% 7,999 (31) 113 (1.41) 1.11 (0.88–1.41)
 25%–75% 13,871 (54) 176 (1.27) Reference
 >75% 3,661 (15) 51 (1.39) 1.10 (0.81–1.50)
NOTE. SSI, surgical site infection; IQR, interquartile range; ASA, American Society of Anesthesiology.
a
Unadjusted risk ratio with 95% confidence intervals.
b
Hip arthroplasty operative duration: <25% = <61 min; 25%–75% =61–105 min; >75% =>105 min.
c
Surgeon median operative duration: <25% = <70 min; 25%–75% =70–104 min; >75% =>104 min.
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